Spots Global Cancer Trial Database for 4-aminopyridine Treatment for Nerve Injury
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: 4-aminopyridine Treatment for Nerve Injury
Official Title: 4-aminopyridine Treatment for Nerve Injury Resulting From Radical Retro-Pubic Prostatectomy
Study ID: NCT03701581
Study Description
Brief Summary: To evaluate the role of 4-aminopyridine (4-AP) on the course of recovery after peripheral nerve traction and/or crush injury. This study aims to test the hypothesis that 4-aminopyridine speeds the often slow and unpredictable recovery after peripheral nerve traction and/or crush injuries.
Detailed Description: To evaluate the role of 4-AP on the recovery of nerve function we will be giving patients with prostate cancer who are undergoing robot assisted radical prostatectomy (RP) either 4-AP or placebo in the perioperative period. This population of patients was selected as nerve crush injury during RP is thought to contribute to erectile dysfunction and urinary continence post operatively.
Eligibility
Minimum Age: 45 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
University of Rochester Department of Urology, Rochester, New York, United States
University of Rochester Medical Center, Rochester, New York, United States
Contact Details
Name: Thomas Osinski, MD
Affiliation: University of Rochester, Department of Urology
Role: PRINCIPAL_INVESTIGATOR
Name: John Elfar, MD
Affiliation: University of Rochester, University of Arizona
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
